Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing

Saved in:
Bibliographic Details
Published in:Cancer Management and Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553943616847872
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Management and Research
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:91715
institution FRELIP
journal_source_facet Cancer Management and Research
last_indexed 2026-06-20T21:44:45.448Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
title_alt Terapias dirigidas a CLDN18.2 en adenocarcinoma gástrico y de la unión gastroesofágica: evaluación de biomarcadores, dinámica de expresión y secuenciación del tratamiento
Thérapies ciblant CLDN18.2 dans l'adénocarcinome gastrique et de la jonction gastro-œsophagienne : évaluation des biomarqueurs, dynamique d'expression et séquencement du traitement
Terapêuticas Direcionadas a CLDN18.2 no Adenocarcinoma Gástrico e da Junção Gastroesofágica: Avaliação de Biomarcadores, Dinâmica de Expressão e Sequenciamento de Tratamento
title_auth CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
title_es_txt Terapias dirigidas a CLDN18.2 en adenocarcinoma gástrico y de la unión gastroesofágica: evaluación de biomarcadores, dinámica de expresión y secuenciación del tratamiento
title_fr_txt Thérapies ciblant CLDN18.2 dans l'adénocarcinome gastrique et de la jonction gastro-œsophagienne : évaluation des biomarqueurs, dynamique d'expression et séquencement du traitement
title_full CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
title_fullStr CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
title_full_unstemmed CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
title_pt_txt Terapêuticas Direcionadas a CLDN18.2 no Adenocarcinoma Gástrico e da Junção Gastroesofágica: Avaliação de Biomarcadores, Dinâmica de Expressão e Sequenciamento de Tratamento
title_short CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
title_sort cldn18.2-directed therapeutics in gastric and gastroesophageal junction adenocarcinoma: biomarker assessment, expression dynamics, and treatment sequencing
topic Oncology
General
Oncology
url https://www.dovepress.com/cldn182-directed-therapeutics-in-gastric-and-gastroesophageal-junction-peer-reviewed-fulltext-article-CMAR